代谢参数作为头颈癌预后因素为肿瘤分期增值
该回顾性研究分析62例接受放疗±同期化疗的头颈鳞癌患者,用18F-FDG PET以肝脏依赖SUV阈值测量治疗前代谢肿瘤体积(MTV)和总病灶糖酵解(TLG)。Cox回归显示高MTV(>37 ml)和高TLG(>247 g)均独立关联更差的无病生存(DFS)和总生存(OS)。MTV和TLG可作为HNSCC独立预后因素,易于获取,有助于预测临床结局。
要点
- 高MTV(>37 ml)独立关联更差DFS(HR=3.45)和OS(HR=3.27)。
- 高TLG(>247 g)独立关联更差DFS(HR=3.32)和OS(HR=3.42)。
- MTV和TLG易于获取,可作为HNSCC独立预后因素。
核心结论
- MTV和TLG可视为HNSCC患者DFS和OS的独立预后因素。
- 鉴于其易于获取,可能有助于预测这些患者的临床结局。
研究设计与样本
- 回顾性分析62例接受放疗±同期化疗的HNSCC患者。
- 治疗前用18F-FDG PET以肝脏依赖SUV阈值测量MTV和TLG。
- 采用Cox回归分析寻找与DFS和OS的关联。
主要发现
- 高MTV(>37 ml)独立关联更差DFS(HR=3.45;95%CI 1.52-7.84)和OS(HR=3.27;95%CI 1.41-7.57)。
- 高TLG(>247 g)独立关联更差DFS(HR=3.32;95%CI 1.44-7.65)和OS(HR=3.42;95%CI 1.45-8.07)。
关键数值与推荐
- MTV阈值>37 ml,TLG阈值>247 g,基于肝脏依赖SUV阈值测量。
临床怎么用
- 治疗前18F-FDG PET测量的MTV和TLG可辅助预测HNSCC患者DFS和OS。
- 高MTV(>37 ml)或高TLG(>247 g)提示预后更差,可考虑强化风险分层。
局限性
- 回顾性研究,样本量62例,结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Validated biomarkers in head and neck squamous cell carcinoma (HNSCC) are scarce. METHODS: We retrospectively analyzed 62 patients with HNSCC treated with radiotherapy +/- concurrent chemotherapy. Pretreatment metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were measured in a 18 F-FDG positron emission tomography using a liver dependent standardized uptake value threshold. Cox regression analyses were performed to find associations with disease-free survival (DFS) and overall survival (OS). RESULTS: High values of MTV (>37 ml) were independently associated with a worse DFS (hazard ratio [HR] = 3.45; 95% confidence interval [CI], 1.52-7.84) and OS (HR = 3.27; 95% CI, 1.41-7.57). Similar results were found for high values of TLG (>247 g) for DFS (HR = 3.32; 95% CI, 1.44-7.65) and OS (HR = 3.42; 95% CI, 1.45-8.07). CONCLUSIONS: MTV and TLG can be considered as independent prognostic factors for DFS and OS in patients with HNSCC. Considering how easily obtainable they are, they may be useful for predicting clinical outcomes in these patients.
引用
- Rijo-Cedeño J, Mucientes J, Seijas Marcos S, et al. Adding value to tumor staging in head and neck cancer: The role of metabolic parameters as prognostic factors. Head Neck. 2021. PMID: 33955080. doi:10.1002/hed.26725
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。